In tumors associated with CNC as well as in thyroid and adrenal tumors with downregulation of PRKAR1A, allelic losses of the 17q22–24 PRKAR1A chromosomal locus are frequently identified and are associated with changes in PKA activity [26,27,28,29]. The gene discussed is PRKAR1A; the disease is adrenal gland neoplasm.